Surgical robot developer Ronovo Surgical has secured 300 million yuan ($41.3 million) in a Series B financing round co-led by state-owned Wuxi Guolian Group.
Ince Capital, a Chinese venture investment firm that targets early- and growth-stage companies across tech, Internet, and consumer-focused industries, also led the round, according to a release on June 14.
The round saw the participation of King Star Med LP, a venture fund specialising in healthcare and biotech investments, and existing shareholder LongRiver Investments. The firm will use the proceeds to accelerate the commercialisation of Ronovo Surgical’s Carina platform, which claims to be the first modular laparoscopic robotic surgery system developed in China.
Founded in 2019, the Shanghai-headquartered firm raised 200 million yuan ($27.4 million) in a pre-Series B+ financing round led by Beijing-headquartered venture capital firm NRL Capital in August 2023.
CHINA DEAL MONITOR
DealStreetAsia has also compiled a table listing all prominent venture capital transactions in Greater China from June 10 –16, 2024.
